-21%
4X Tested - ISO 17025
Cognitive Peptide

Semax Nasal

Certificate of Analysis

Semax is a synthetic heptapeptide analog of ACTH(4-10) developed in Russia, studied for its nootropic, neuroprotective, and neurorestorative properties in preclinical and clinical research.

BUNDLE & SAVE
2-Day Shipping

Free Shipping
over $200

Free shipment
protection

Secure Checkout
256-bit SSL


Description

What is Semax Nasal?

Semax is a synthetic heptapeptide based on a fragment of adrenocorticotropic hormone (ACTH), specifically the sequence ACTH(4-10) with the addition of a Pro-Gly-Pro C-terminal tripeptide that enhances metabolic stability. It was developed at the Institute of Molecular Genetics of the Russian Academy of Sciences.

Semax has been approved in Russia and several CIS countries as a prescription medication for the treatment of stroke, cognitive disorders, and peptic ulcers. It is one of the few peptides with regulatory approval for cognitive applications, though it has not been evaluated by the FDA or EMA.

Research has focused on its effects on brain-derived neurotrophic factor (BDNF) expression, neurotransmitter modulation, and neuroprotection. Semax has shown activity in preclinical models of stroke, traumatic brain injury, and neurodegenerative conditions.

Research-grade Semax is sold strictly for laboratory and research purposes only.


Research Applications

Areas of Investigation
Brain Protection

Neuroprotection

Studied for protective effects on neurons in models of stroke, traumatic brain injury, and oxidative stress.
Cognition

Cognitive Enhancement

Investigated for its effects on memory, attention, and learning through BDNF upregulation and neurotransmitter modulation.
BDNF

BDNF & Neurotrophin Research

Researched for its ability to increase brain-derived neurotrophic factor expression, supporting neuronal survival and synaptic plasticity.
Neurotransmitters

Neurotransmitter Modulation

Explored for effects on dopaminergic and serotonergic systems in preclinical models.

Compound Profile

Technical specifications
What is Semax Nasal?

Molecular Profile


Sequence
MEHFPGP
Molecular Formula
C₃₇H₅₁N₉O₁₀S
Molecular Weight
813.93 g/mol
Appearance
White lyophilized powder

Form

Lyophilized (freeze-dried)
Handling & Shelf Life Guidelines

Storage & Stability


Storage (Pre-Reconstitution)

Store below -18°C, desiccated, away from light and moisture.
Storage (Post-Reconstitution)
Refrigerate at 2–8°C. For longer storage, aliquot and store below -18°C. Avoid freeze-thaw cycles.
Shelf Life
24 months from date of manufacture when stored as directed
Sensitivity Notes
Sensitive to heat, light, and moisture. Contains methionine susceptible to oxidation. Keep sealed until use.
Compliance & Clinical Overview

Regulatory & Research Status


FDA Status
Not FDA approved. Approved in Russia for stroke, cognitive disorders, and peptic ulcers.
WADA Classification
Not currently specifically listed as a prohibited substance.
Clinical Trial Status
Published studies on BDNF expression, neuroprotection, cognitive enhancement, and neurotransmitter modulation.
Published Studies
Published studies on BDNF expression, neuroprotection, cognitive enhancement, and neurotransmitter modulation.
Research Disclaimer
For laboratory and research purposes only. Not intended for human consumption.

COA's (Certificate of Analysis)

Third Party Tested by Freedom Diagnostics
99.90%
Purity
Variant
Semax
Lot #
GL-2609-035
Labelled
10mg
Actual
10.49mg
Tested
9/14/2026
View COA
(opens in a new tab)
99.86%
Purity
Variant
Semax
Lot #
SEM10-GL01
Labelled
10mg
Actual
10.66mg
Tested
6/24/2026
View COA
(opens in a new tab)

Frequently Asked Questions

Common questions about Semax Nasal research